BMC

Saratoga Investment Corp. Announces Fiscal Year-End and Fourth Quarter 2024 Financial Results

Retrieved on: 
Montag, Mai 6, 2024
BMC, Investment, SBIC, SBA, Webcast, Accounts payable, JV, AUM, Grace note, Lisp (programming language), U.S. Bancorp, National Association, Tax, Calendar, CLO, BDC, Management, ATM, Sale, Ladenburg Thalmann, NAV, Depreciation, NII, IRR, Environment, Share repurchase, Bank statement, Credit

Since Saratoga Investment took over the management of the BDC, $917.0 million of repayments and sales of investments originated by Saratoga Investment have generated a gross unlevered IRR of 15.7%.

Key Points: 
  • Since Saratoga Investment took over the management of the BDC, $917.0 million of repayments and sales of investments originated by Saratoga Investment have generated a gross unlevered IRR of 15.7%.
  • As compared to the quarter ended November 30, 2023, total investment income grew by $0.9 million, or 2.5%, from $36.3 million.
  • Net investment income on a weighted average per share basis was $4.49 and $0.94 for the year and quarter ended February 29, 2024.
  • On February 15, 2024, Saratoga Investment announced that its Board of Directors declared a quarterly dividend of $0.73 per share for the fiscal quarter ended February 29, 2024, paid on March 28, 2024, to all stockholders of record at the close of business on March 13, 2024.

Accelera Battery System to Power BMC Otomotiv Electric Transit Buses in Europe

Retrieved on: 
Dienstag, Mai 7, 2024
Automotive, Technology, EV, Electric Vehicles, Transport, Batteries, Public Transport, BMC, City, Kilowatt-hour, NMC, LOI, CMI, LFP

Accelera™ by Cummins, the zero-emissions business segment of Cummins Inc. [NYSE: CMI], is collaborating with BMC Otomotiv, a leading manufacturer of buses and trucks in Turkey and throughout Europe, to provide battery solutions for their transit bus operations.

Key Points: 
  • Accelera™ by Cummins, the zero-emissions business segment of Cummins Inc. [NYSE: CMI], is collaborating with BMC Otomotiv, a leading manufacturer of buses and trucks in Turkey and throughout Europe, to provide battery solutions for their transit bus operations.
  • The companies have signed a letter of intent (LOI) for Accelera to power BMC’s city buses.
  • This marks the first time the BP97E, Accelera’s latest nickel manganese cobalt (NMC) battery pack, will be used in operation in Europe.
  • The BP97E is a high-energy-density battery pack and is the latest development in Accelera’s NMC battery platform.

Boom Foundation To Feed 2 Million Nigerians Through Boomcoin-To-Meals Initiative Amid Ongoing Food Crisis

Retrieved on: 
Dienstag, April 16, 2024
BMC, Food, KYC, Blockchain, Economic development, Cryptocurrency

Lagos, Nigeria, April 16, 2024 (GLOBE NEWSWIRE) --  Boom, a blockchain-based e-commerce ecosystem and digital payments platform, announced the launch of its first Boomcoin-To-Meals (B2M) initiative, which aims to feed two million Nigerians amid the ongoing severe food crisis brought upon by the recent hike in inflation. This initiative will provide vital relief by airdropping 1 Boomcoin (BMC) each to 2 million Nigerians who will be able to purchase food bundles that they can either collect or have delivered to their homes. Boom Foundation has allocated 1 million BMC to this airdrop and has opened the initiative to public donations, which will be matched 1:1 for all donated BMCs, up to an additional 500,000 BMC.

Key Points: 
  • Lagos, Nigeria, April 16, 2024 (GLOBE NEWSWIRE) --  Boom, a blockchain-based e-commerce ecosystem and digital payments platform, announced the launch of its first Boomcoin-To-Meals (B2M) initiative, which aims to feed two million Nigerians amid the ongoing severe food crisis brought upon by the recent hike in inflation.
  • Headline inflation, which hit a high of 31.7% in February , has eroded consumer spending power, leading to one in ten Nigerians currently facing food insecurity .
  • This means that nearly 22 million people in Nigeria are unable to feed themselves and their families.
  • In collaboration with local food vendors, Boom has designed these food packages to provide 2 million Nigerians with all the essentials to feed their families for a day.

Prism Places Surges to $2.5 Billion in Assets

Retrieved on: 
Dienstag, April 23, 2024
Personality, BMC, McWhinney, Fortification, Foothills Mall, Investment, CRE, Partnership, Alchemy, Life, DNA, Marketing, NOI, Growth, Telescopic sight

LOS ANGELES , April 23, 2024 /PRNewswire/ -- Today, Prism Places, an innovative CRE management and investment firm, shares a milestone: its assets under management have surged to $2.5 billion in less than three years. Since launch in February 2021, Prism has quietly assembled a premiere portfolio of over 2.7 million square feet which includes high-quality, legacy properties in major markets; mixed-use new developments that are industry models; and challenged mall projects that demand operational precision and visionary redevelopment.

Key Points: 
  • LOS ANGELES , April 23, 2024 /PRNewswire/ -- Today, Prism Places , an innovative CRE management and investment firm, shares a milestone: its assets under management have surged to $2.5 billion in less than three years.
  • The projects are united by a goal: to create "places with purpose" by embracing local culture, fostering community and generating extraordinary value for Prism's stakeholders.
  • "We founded Prism to fill the void of great operators in today's market," said Stenn Parton, Prism's Founder and CEO.
  • "I am proud of the Prism team and the amazing growth we have accomplished over the last three years.

Nu.Q® Vet Cancer Test launched in-clinic in U.S. and Europe through Antech

Retrieved on: 
Dienstag, April 23, 2024
Cancer, BMC, Pet, Sepsis, Veterinarian, Death, Volition, Neutrophil extracellular traps, Analyser, Dog, Plasma, Element, Vaccine

HENDERSON, Nev., April 23, 2024 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, has announced that its Nu.Q® Vet Cancer Test is now available in-clinic to veterinarians across the U.S and Europe through Antech , a leading veterinary diagnostics company.

Key Points: 
  • HENDERSON, Nev., April 23, 2024 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, has announced that its Nu.Q® Vet Cancer Test is now available in-clinic to veterinarians across the U.S and Europe through Antech , a leading veterinary diagnostics company.
  • By incorporating the Nu.Q® Canine Cancer Test into annual checkups or regular senior wellness exams, veterinarians can detect cancer¹ earlier and help pet owners make timely, informed decisions about cancer care."
  • Volition's original license and supply agreement was between Belgian Volition SRL and Heska, an Antech company, part of Mars Science & Diagnostics.
  • https://doi.org/10.1186/s12917-022-03429-8
    According to The Veterinary Cancer Society,  one in four dogs will be diagnosed with cancer, and it's the leading cause of death in pets who are beyond middle age.

BMC Reveals 2024 Solution Provider Partners of the Year

Retrieved on: 
Dienstag, April 23, 2024
BMC, DBA, Ecosystem, Innovation, Intelligence, Transformation, ITIL, Partner

HOUSTON, April 23, 2024 /PRNewswire/ -- BMC, a global leader in software solutions for the Autonomous Digital Enterprise, today announced its annual Solution Provider Partner of the Year award winners at the annual BMC Sales Kickoff in Las Vegas, including the company's partner ecosystem. As part of the company strategy, BMC is committed to accelerating the BMC customer experience as the strategic partner for its customers' business transformation journeys with the strength of the BMC ecosystem.

Key Points: 
  • HOUSTON, April 23, 2024 /PRNewswire/ -- BMC, a global leader in software solutions for the Autonomous Digital Enterprise, today announced its annual Solution Provider Partner of the Year award winners at the annual BMC Sales Kickoff in Las Vegas, including the company's partner ecosystem.
  • As part of the company strategy, BMC is committed to accelerating the BMC customer experience as the strategic partner for its customers' business transformation journeys with the strength of the BMC ecosystem.
  • The BMC Solution Provider Partner awards celebrate partners who collaborate with BMC to drive innovation and transformation for customers, showcasing excellence across the partner community through consistent growth and technical certifications.
  • BMC Partner Ecosystem Solution Providers across the world were recognized across various categories, including regional awards for Partner of the Year, Digital Business Automation (DBA), Digital Service and Operations Management (DSOM), Intelligent Z Optimization and Transformation (IZOT), and global awards for Innovation, Technology, and Service Delivery.

Boston Medical Center Study Furthers Understanding of Lung Regeneration

Retrieved on: 
Montag, April 22, 2024
Mortality, Boston Medical Center, BMC, Cell Stem Cell, Cell, Chronic obstructive pulmonary disease, Boston University, Transplant, Regenerative medicine, Health, Bacteria, Respiratory disease, MD, Doctor of Philosophy, Disease, Respiratory system, Engineering, Acute respiratory distress syndrome, Pulmonary fibrosis, AT1, Science, Medicine, Knowledge, Infection, COPD, Vaccine

BOSTON, April 22, 2024 /PRNewswire/ -- Researchers at Boston Medical Center (BMC) and Boston University (BU) today announced findings from a new research study, published in Cell Stem Cell, detailing the development of a method for generating human alveolar epithelial type I cells (AT1s) from pluripotent stem cells (iPSCs).

Key Points: 
  • BOSTON, April 22, 2024 /PRNewswire/ -- Researchers at Boston Medical Center (BMC) and Boston University (BU) today announced findings from a new research study, published in Cell Stem Cell, detailing the development of a method for generating human alveolar epithelial type I cells (AT1s) from pluripotent stem cells (iPSCs).
  • As science and medicine have progressed, researchers have identified a clear need for additional knowledge about lung cells to help improve patient health.
  • "Uncovering the ability to generate human alveolar epithelial type I cells (AT1s), and similar cell types, from pluripotent stem cells (iPSCs), has expanded our knowledge of biological processes and can significantly improve disease understanding and management," said Darrell Kotton, MD, Director, Center for Regenerative Medicine (CReM) of Boston University and Boston Medical Center.
  • This new study also furthers the CReM's goal of generating every human lung cell type from iPSCs as a pathway to improving disease management and provides a source of cells for future transplantation to regenerate damaged lung tissues in vivo.

Chicago based AiRo Digital Labs acquires Cloudaction to create Top 10 fastest growing AI & Cloud consulting firm in the US

Retrieved on: 
Donnerstag, April 18, 2024
Computer vision, ServiceNow, BMC, AI, Computer, HFS, Data, Microsoft, Acquisition, Azure

CHICAGO, April 18, 2024 /PRNewswire/ -- In a move poised to create Top 10 fastest growing AI & Cloud consulting firms in the US, AiRo Digital Labs (AiRo), a well-known Chicago based provider of transformative AI and Cloud solutions, today announced the strategic acquisition of Cloudaction, a prominent cloud solutions provider with significant capabilities in Salesforce, ServiceNow, BMC suite, Microsoft Azure and many other advanced skills in the Cloud and AI space.

Key Points: 
  • CHICAGO, April 18, 2024 /PRNewswire/ -- In a move poised to create Top 10 fastest growing AI & Cloud consulting firms in the US, AiRo Digital Labs (AiRo), a well-known Chicago based provider of transformative AI and Cloud solutions, today announced the strategic acquisition of Cloudaction, a prominent cloud solutions provider with significant capabilities in Salesforce, ServiceNow, BMC suite, Microsoft Azure and many other advanced skills in the Cloud and AI space.
  • This acquisition reaffirms AiRo position at the forefront of AI & cloud management, bringing together hundreds of Cloudaction employees globally within AiRo's Cloud practice.
  • AiRo has received multiple awards from Forbes, Inc5000, Crain's Chicago, HFS and most recently Great Place to Work certification
    The Founder and Chief Executive Officer of AiRo, Dev Singh said, "This strategic move marks a new chapter in the amazing growth journey of AiRo and positions us as a leading force in AI & Cloud consulting space."
  • Samir Kumar, Co-founder and President of Cloudaction, echoed the sentiment, "Joining forces with AiRo creates a supercharged AI & Cloud consulting powerhouse".

BMC to Acquire Netreo

Retrieved on: 
Dienstag, April 16, 2024
BMC, Risk, NPMD, Helix, APM, DevOps, ITIM, Acquisition, Root cause analysis, Overalls, Asset management

HOUSTON , April 16, 2024 /PRNewswire/ -- BMC, a global leader in software solutions for the Autonomous Digital Enterprise, today announced the signing of a definitive agreement to acquire Netreo, the award-winning provider of smart and secure IT network and application observability solutions. With Netreo, the BMC Helix platform will provide customers with a full-stack, open observability, and AIOps solution. The deal is expected to close in the first half of 2024, subject to customary closing conditions. Financial terms of the transaction were not disclosed. 

Key Points: 
  • HOUSTON , April 16, 2024 /PRNewswire/ -- BMC , a global leader in software solutions for the Autonomous Digital Enterprise , today announced the signing of a definitive agreement to acquire Netreo , the award-winning provider of smart and secure IT network and application observability solutions.
  • With Netreo, the BMC Helix platform will provide customers with a full-stack, open observability, and AIOps solution.
  • Netreo's OpenTelemetry-based observability, APM, and NPMD are a perfect complement to the industry recognized BMC Helix observability, AIOps, and ServiceOps solutions," said Margaret Lee, senior vice president and general manager of Digital Service and Operations Management at BMC.
  • With this acquisition, BMC continues to invest in innovation – from IT operations management to service management, data and application workflow automation, and mainframe management.

Lipocine Announces Positive LPCN 2401 Clinical Results Showing Improved Body Composition in Participants with Obesity

Retrieved on: 
Donnerstag, April 11, 2024
Pelvis, FDA, Safety, Weight, BMC, Comorbidity, Facial muscles, LM, Conference call, BMI, Testosterone, Weight loss, Rib, DEXA, Webcast, Obesity, Week, Dyslipidemia, Type 2 diabetes, Body composition, Patient, Hypertension, 3rd millennium, Dietary supplement

Furthermore LPCN 2401 could help to attenuate collateral fattening and rebound fat/weight "overshoot" associated with discontinuation of GLP-1/GIP agonists.

Key Points: 
  • Furthermore LPCN 2401 could help to attenuate collateral fattening and rebound fat/weight "overshoot" associated with discontinuation of GLP-1/GIP agonists.
  • We look forward to meeting with the FDA to discuss the further development of LPCN 2401 as an aid to weight management interventions."
  • Analyses of body composition parameters, including prespecified endpoints of whole body LM and whole-body FM, are reported in the table below.
  • An overall improvement in body composition is evidenced by substantial decrease in the fat mass to lean mass ratio.